Abstract
In recent years, many efforts have focused on combined radiotherapy and chemotherapy as adjuvants to curative surgery in patients with stage II and III (UICC) rectal carcinomas. Intraoperative radiotherapy (IORT) makes it possible to increase the total irradiation dose in a locally restricted area while sparing normal mobile organs, but it is limited by increased late toxicity. A prospective phase I/II study was designed to evaluate the efficacy of moderate-dose intraoperative and external beam radiotherapy (IO-EBRT), in some cases with concomitant chemotherapy.
Sixty-three patients with a stage II or III rectal carcinoma were eligible for analysis (median follow-up 30.6 months). Fifty-four patients had undergone a complete resection (R0). Mean IORT dose was 11.3 Gy and mean EBRT dose 41.4 Gy. In 45 patients (71.4%) concomitant chemotherapy was delivered (5-FU, leucovorin).
Two patients suffered local failure. However, overall local tumor control was markedly improved compared to historical controls (96.8% vs 66.2%). Patients treated with IO-EBRT showed a reduced incidence of distant metastases after concomitant chemotherapy (17.6% vs 38.8%). A 4-year actuarial relapse-free survival of 82% was obtained after IO-EBRT plus chemotherapy, and 59% after IO-EBRT alone. The postoperative course was unremarkable in 47.6% of patients. No radiation colitis or neuropathy occurred.
Moderate-dose IORT and EBRT is safe, taking into account related late toxicities. It is an effective local treatment approach, resulting in an encouraging local control rate.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Eble MJ, Kallinowski F, Wannenmacher M, Herfarth C (1994) Intraoperative Radiotherapie des lokal ausgedehnten und rezidivierten Rektumkarzinoms. Chirurg 65:585–592
Eble MJ, Wulf J, Kampen M, Weischedel U, Wannenmacher M (1995) Lokal begrenzte Dosiseskalation in der Radiotherapie des primär ausgedehnten und lokal rezidivierten Rektumkarzinoms. Strahlenther Onkol 171:77–86
Gunderson LL, Russell AH, Lewellyn HJ, Doppke KP, Tepper JE (1985) Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 11:1379–1393
Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, Fiedck JM, Wolff B, Dozois R, O’Conell MJ (1997) Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/-5-FU. Int J Radiat Oncol Biol Phys 37:601–614
Letschert JGJ, Lebesque JV, de Boer RW, Hart AAM, Bartelink H (1990) Dose-volume correlation in radiation-related small bowel complications: a clinical study. Radiother Oncol 18:307–320
Mak A, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Romsdahl MM (1994) Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 28:597–603
NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 1264:1444–1450
Saxton JP, Withers HR, Romsdahl MM, Borgelt BB (1982) The use of irradiation therapy in the treatment of tumors of the rectum of rectosigmoid. J Natl Med Assoc 74:529–533
Shaw EG, Gunderson LL, Martin JK (1990) Peripheral nerve and ureteral tolerance of intraoperative radiation therapy: clinical and dose response analysis. Radiother Oncol 18:247–261
Vigliotti A, Rich TA, Romsdahl MM, Withers HR, Oswald MJ (1987) Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 13:999–1006
Weinstein GD, Rich TA, Shumate CR, Skibber JM, Clearly KR, Ajani JA, Ota DM (1995) Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 32:197–204
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag · Berlin Heidelberg
About this paper
Cite this paper
Eble, M.J., Lehnert, T., Herfarth, C., Wannenmacher, M. (1998). Intraoperative Radiotherapy as Adjuvant Treatment for Stage II/III Rectal Carcinoma. In: Schlag, P.M. (eds) Rectal Cancer. Recent Results in Cancer Research, vol 146. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71967-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-71967-7_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71969-1
Online ISBN: 978-3-642-71967-7
eBook Packages: Springer Book Archive